Advance Search | Bentham Science

Update of QSAR & Docking Studies of the GSK-3 Inhibitors

Journal: Current Bioinformatics
Volume: 6 Issue: 2 Year: 2011 Page: 215-232
Author(s): Isela Garcia, Yagamare Fall, Generosa Gomez

The Possible Involvement of Glycogen Synthase Kinase-3 (GSK-3) in Diabetes, Cancer and Central Nervous System Diseases

Journal: Current Pharmaceutical Design
Volume: 17 Issue: 2 Year: 2011 Page: 2264-2277
Author(s): Amar S., Belmaker R.H., Agam G.

EPO Relies upon Novel Signaling of Wnt1 that Requires Akt1, FoxO3a,GSK-3β, and β-Catenin to Foster Vascular Integrity during Experimental Diabetes

Journal: Current Neurovascular Research
Volume: 8 Issue: 2 Year: 2011 Page: 103-120
Author(s): Zhao Zhong Chong, Jinling Hou, Yan Chen Shang, Shaohui Wang, Kenneth Maiese

The Potential Role of Glycogen Synthase Kinase 3 Inhibitors as Amyotrophic Lateral Sclerosis Pharmacological Therapy

Journal: Current Medicinal Chemistry
Volume: 18 Issue: 2 Year: 2011 Page: 3028-3034
Author(s): V. Palomo, D. I. Perez, C. Gil, A. Martinez

Multiplex Analysis of Cardiac Hypertrophic Signaling: Reduced in vivo Phosphorylation of Glycogen Synthase Kinase-3β and Proline-Rich Akt Substrate (PRAS40)

Journal: Current Signal Transduction Therapy
Volume: 6 Issue: 1 Year: 2011 Page: 65-70
Author(s): Jens R. Larsen, Morten Smerup, Rikke Norregaard, Jane H. Christensen, Kim Sivesgaard, Sara D. Christensen, Karin Christensen, Erik Sloth, Peter Torp, Niels Gregersen, J. Michael Hasenkam

Overcoming Cell Death and Tau Phosphorylation Mediated by PI3KInhibition: A Cell Assay to Measure Neuroprotection

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10 Issue: 2 Year: 2011 Page: 208-214
Author(s): D. Simon, M. Medina, J. Avila, F. Wandosell

Lithium and its Neuroprotective and Neurotrophic Effects: Potential Treatment for Post-Ischemic Stroke Sequelae

Journal: Current Drug Targets
Volume: 12 Issue: 2 Year: 2011 Page: 243-255
Author(s): A. B. Gold, N. Herrmann, K. L. Lanctot

Association Analysis of Nuclear Receptor Rev-erb Alpha Gene (NR1D1) and Japanese Methamphetamine Dependence

Journal: Current Neuropharmacology
Volume: 9 Issue: 1 Year: 2011 Page: 129-132
Author(s): Taro Kishi, Tsuyoshi Kitajima, Kunihiro Kawashima, Tomo Okochi, Yoshio Yamanouchi, Yoko Kinoshita, Hiroshi Ujike, Toshiya Inada, Mitsuhiko Yamada, Naohisa Uchimura, Ichiro Sora, Masaomi Iyo, Norio Ozaki, Nakao Iwata

Evaluation of Different Approaches to Identifying a Higher Throughput Assay for Time-Dependent Inhibition (TDI)

Journal: Drug Metabolism Letters
Volume: 5 Issue: 2 Year: 2011 Page: 104-113
Author(s): M. Kajbaf, R. Longhi, S. Fontana

New Strategies in the Development of Antidepressants: Towards the Modulation of Neuroplasticity Pathways

Journal: Current Pharmaceutical Design
Volume: 17 Issue: 5 Year: 2011 Page: 521-533
Author(s): Rebeca Vidal, Fuencisla Pilar-Cuellar, Severiano dos Anjos, Raquel Linge, Begona Treceno, Veronica Ines Vargas, Antonio Rodriguez-Gaztelumendi, Ricardo Mostany, Elena Castro, Alvaro Diaz, Elsa M. Valdizan, Angel Pazos

Search

Find Journals, Volumes, Issues, Articles, Ebooks and Chapters

Search Result "GSK"